Gameto Raises $44M for Phase 3 Stem Cell Reproductive Care Trial
The Series C funding enables Gameto to complete the ongoing Phase 3 trial for its lead program, Fertilo, and file for regulatory approvals globally. Fertilo is already cleared to commercialize many ex-U.S. jurisdictions and is currently used in clinics in Peru, Mexico and Australia, with additional clearances in Japan, India, Singapore, Guatemala, Argentina, Dominican Republic, and Paraguay. Five babies have been born with Fertilo so far […]
UNLOCKINGTHEOPPORTUNITY
